#United States #New York #Class Action #Gross Law Firm #Iovance Biotherapeutics

Recover Your Losses with the Class Action Suit Against Iovance Biotherapeutics

Are you a shareholder of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) who has sustained losses due to the company's declining stock performance? The Gross Law Firm has an important announcement that may provide you with the opportunity to recover your investments.

Background

Iovance Biotherapeutics has come under scrutiny after delivering disappointing financial results that have had a dramatic impact on its stock prices. The company is facing allegations of providing optimistic projections to investors while obscuring critical information about its growth potential. Specifically, it has been suggested that the company was not adequately prepared to meet market demand for its therapies.

During the class action period from May 9, 2024, to May 8, 2025, severe misrepresentations were made about the company's capabilities and market position. Following a significant announcement on July 25, 2024, regarding reduced revenue guidance, the stock plummeted nearly 45% in one day, a stark warning of the realities many investors faced.

Class Action Suit Details

Shareholders who purchased IOVA shares during the class action timeframe are encouraged to take action. The Gross Law Firm is inviting you to consider joining their efforts to recover losses through a class action lawsuit. Notably, becoming a lead plaintiff is not mandatory to participate in compensation efforts.

• - Important Dates:

- Deadline for registration: July 14, 2025
- Class action period: May 9, 2024 - May 8, 2025

• - Next Steps: Those interested in pursuing recovery must register their information with the Gross Law Firm. Once registered, you will be enrolled in a monitoring service that will keep you updated on the case's progress. Joining is free and carries no obligations.

Why Choose The Gross Law Firm?

The Gross Law Firm has established itself as a serious advocate for investors facing losses caused by unethical business practices. Their mission focuses on protecting investor rights and ensuring corporate transparency. The firm believes in holding companies accountable and requires them to disclose pertinent data that impacts stock valuations. Their commitment goes beyond just financial recovery; they aim to make a significant change in how companies interact with their investors.

Contact Information

For additional details regarding this suit or to register your claim, please get in touch with:

• - The Gross Law Firm

15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

This is a call to all shareholders of Iovance Biotherapeutics. Now is your chance to take a stand against financial loss! Make sure you register your information before the deadline and participate in the recovery process. Your voice can help advocate for corporate responsibility and equitable treatment in the financial sector.